Therefore, our study here discloses that the EGF–ERK1/2 signaling pathway is a regulatory mechanism that governs glycolysis-derived serine flux in breast cancer cells through the spatial regulation of large-sized glucosomes. The gene discussed is EGF; the disease is breast carcinoma.